348 related articles for article (PubMed ID: 8579894)
1. Present and future of osteoporosis therapy.
Seeman E; Tsalamandris C; Bass S; Pearce G
Bone; 1995 Aug; 17(2 Suppl):23S-29S. PubMed ID: 8579894
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis: trials and tribulations.
Seeman E
Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
[TBL] [Abstract][Full Text] [Related]
3. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
4. [Fluorides and bisphosphonates in the treatment of osteoporosis].
Ringe JD
Orthopade; 2001 Jul; 30(7):456-61. PubMed ID: 11515184
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of bone fragility in men.
Seeman E
Bone; 1999 Jul; 25(1):143-7. PubMed ID: 10423041
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
[TBL] [Abstract][Full Text] [Related]
7. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone.
Hunziker J; Wronski TJ; Miller SC
J Dent Res; 2000 Jun; 79(6):1431-8. PubMed ID: 10890724
[TBL] [Abstract][Full Text] [Related]
8. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis - Evidence based therapy].
Minne HW; Begerow B; Pfeifer M
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S57-S61. PubMed ID: 11930292
[TBL] [Abstract][Full Text] [Related]
10. Is cortical bone hip? What determines cortical bone properties?
Epstein S
Bone; 2007 Jul; 41(1 Suppl 1):S3-8. PubMed ID: 17466615
[TBL] [Abstract][Full Text] [Related]
11. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
Delaney MF
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
[TBL] [Abstract][Full Text] [Related]
12. [Indications and limitations of non-hormonal treatments of osteoporosis].
Avouac B
Rev Fr Gynecol Obstet; 1993; 88(7-9):419-23. PubMed ID: 8235256
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of parathyroid hormone.
Cosman F; Lindsay R
Curr Osteoporos Rep; 2004 Mar; 2(1):5-11. PubMed ID: 16036076
[TBL] [Abstract][Full Text] [Related]
14. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
Schacht E
Z Rheumatol; 1994; 53(5):274-98. PubMed ID: 7810237
[TBL] [Abstract][Full Text] [Related]
15. Current bone mineral density data on bisphosphonates in postmenopausal osteoporosis.
McClung MR
Bone; 1996 Nov; 19(5 Suppl):195S-198S. PubMed ID: 8922662
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis in men.
Seeman E
Baillieres Clin Rheumatol; 1997 Aug; 11(3):613-29. PubMed ID: 9367040
[TBL] [Abstract][Full Text] [Related]
18. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
19. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Delmas PD; Vergnaud P; Arlot ME; Pastoureau P; Meunier PJ; Nilssen MH
Bone; 1995 Jun; 16(6):603-10. PubMed ID: 7669436
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis management.
Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
